Davidson Investment Advisors Sells 13,776 Shares of Corteva, Inc. $CTVA

Davidson Investment Advisors trimmed its position in Corteva, Inc. (NYSE:CTVAFree Report) by 5.7% during the second quarter, HoldingsChannel.com reports. The fund owned 230,036 shares of the company’s stock after selling 13,776 shares during the period. Davidson Investment Advisors’ holdings in Corteva were worth $19,482,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the company. EFG International AG bought a new stake in Corteva in the second quarter valued at approximately $25,000. Compass Financial Management LLC acquired a new position in shares of Corteva in the 2nd quarter valued at $25,000. JPL Wealth Management LLC bought a new stake in shares of Corteva in the 3rd quarter valued at $25,000. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva in the 4th quarter valued at $27,000. Finally, Bank of Jackson Hole Trust acquired a new stake in Corteva during the 4th quarter worth $28,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on CTVA shares. Mizuho boosted their target price on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Morgan Stanley raised their price target on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. UBS Group decreased their price objective on Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a research report on Tuesday, August 18th. Barclays increased their target price on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Finally, Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Read Our Latest Stock Report on CTVA

Corteva Stock Performance

Shares of CTVA stock opened at $84.00 on Friday. The firm has a market cap of $56.04 billion, a PE ratio of 55.63, a P/E/G ratio of 2.58 and a beta of 0.57. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The company’s fifty day simple moving average is $82.69 and its 200-day simple moving average is $80.54. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVAGet Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the previous year, the firm posted $2.20 EPS. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Further Reading

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.